Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Dec 2;38(3):461–463. doi: 10.4103/ijmm.IJMM_20_308

Prevalence of COVID-19 Antibodies in Healthcare Workers at the Peak of the Pandemic in Mumbai, India: A Preliminary Study

Tanu Singhal 1,*, Sweta Shah 1, Reshma Naik 1, Amreen Kazi 1, Pooja Thakkar 1
PMCID: PMC7709650  PMID: 33154264

Abstract

Healthcare worker (HCW) infections due to COVID-19 are of serious consequence. Testing for antibodies against COVID-19 in HCWs has been previously recommended. We conducted a serosurvey in HCWs at a private hospital in Mumbai which is treating COVID patients. A total of 244 HCWs were tested. The prevalence of infection in asymptomatic HCWs was 4.3% and in previously symptomatic untested HCWs was 70%. We recommend that HCWs with a previous history of COVID symptoms who were not tested/tested negative by reverse transcription–polymerase chain reaction should be tested for antibodies at least 2 weeks after onset of symptoms.

Keywords: Antibodies, asymptomatic, COVID-19, healthcare workers, India

References

  • 1.The Lancet COVID-19: Protecting health-care workers. Lancet. 2020;395:922. doi: 10.1016/S0140-6736(20)30644-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chang, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020;8:e13. doi: 10.1016/S2213-2600(20)30066-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Indian Council of Medical Research. Newer Additional Strategies for COVID-19 Testing. Available from: https://www.icmr.gov.in/pdf/covid/strategy/New_additional_Advisory_23062020_2.pdf. [Last accessed on 2020 Jul 04].
  • 4.Centers for Disease Control. Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html. [Last accessed on 2020 Jul 04].
  • 5.Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA 2020;10.1001/jama.2020.8259. [DOI] [PubMed]
  • 6.Government of India. Clinical management of COVID 19. Available from: https://www.mohfw.gov.in/pdf/UpdatedClinicalManagementProtocolforCOVID19dated03072020.pdf. [Last accessed on 2020 Jul 04].
  • 7.Meschi S, Colavita F, Bordi L, Matusali G, Lapa D, Amendola A. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test. J Clin Virol. 2020;129:104539. doi: 10.1016/j.jcv.2020.104539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Egger M, Bundschuh C, Wiesinger K. Comparison of the Elecsys® anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma [published online ahead of print, 2020 May 30] Clin Chim Acta. 2020;509:18–21. doi: 10.1016/j.cca.2020.05.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schmidt SB, Grüter L, Boltzmann M, Rollnik JD. Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff. PLoS One. 2020;15:e0235417. doi: 10.1371/journal.pone.0235417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Liu M, Cheng SZ, Xu KW, Yang Y, Zhu QT, Zhang H. Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: Cross sectional study. BMJ. 2020;369:m2195. doi: 10.1136/bmj.m2195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Martin C, Montesinos I, Dauby N, Gilles C, Dahma H, Van Den Wijngaert S. Dynamic of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk health care workers and hospital staff. J Hosp Infect. 2020;106:102–106. doi: 10.1016/j.jhin.2020.06.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6:CD013652. doi: 10.1002/14651858.CD013652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Deng W, Bao L, Liu J, Xiao C, Liu J, Xue J. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369:818–823. doi: 10.1126/science.abc5343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Batisse D, Benech N, Botelho-Nevers E, Bouiller K, Collarino R, Conrad A. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect. 2020 doi: 10.1016/j.jinf.2020.06.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vakharia K. The right to know: ethical implications of antibody testing for healthcare workers and overlooked societal implications. J Med Ethics. 2020 doi: 10.1136/medethics-2020-106467. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Medical Microbiology are provided here courtesy of Elsevier

RESOURCES